BioLineRx

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioLineRx and other ETFs, options, and stocks.

About BLRX

BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. Its product pipeline includes Motaxafortide (BL-8040), which is used for stem-cell mobilization, solid tumors, and acute myeloid lukemia; and AGI-134, which is an immunotherapy treatment used for multiple solid tumors. 

CEO
Philip Adam Serlin
CEOPhilip Adam Serlin
Employees
24
Employees24
Headquarters
Modi'in, HaMerkaz
HeadquartersModi'in, HaMerkaz
Founded
2003
Founded2003
Employees
24
Employees24

BLRX Key Statistics

Market cap
13.54M
Market cap13.54M
Price-Earnings ratio
-1.44
Price-Earnings ratio-1.44
Dividend yield
Dividend yield
Average volume
31.19K
Average volume31.19K
High today
$3.18
High today$3.18
Low today
$2.98
Low today$2.98
Open price
$3.12
Open price$3.12
Volume
12.58K
Volume12.58K
52 Week high
$4.91
52 Week high$4.91
52 Week low
$2.15
52 Week low$2.15

BLRX News

Investing.com 5d
BioLineRx reports preclinical data on GLIX1 with PARP inhibitor - Investing.com

...

BioLineRx reports preclinical data on GLIX1 with PARP inhibitor - Investing.com
TipRanks 6d
BioLineRx and Hemispherian Report GLIX1–PARP Synergy in Ovarian Cancer Model, Plan Trial Expansion

Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new invest...

TipRanks 6d
BioLineRx, Hemispherian announces new preclinical data on GLIX1, PARP inhibitor

BioLineRx (BLRX) announced new preclinical data demonstrating strong synergy between GLIX1 and PARP inhibitors in a patient-derived xenograft model of ovarian c...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.